Optura Secures $17.5 Million Series A from Salesforce Ventures and Echo Health Ventures to Scale its ROAI™ Platform

Optura, a Nashville-based enterprise healthcare platform, has successfully raised $17.5 million in a Series A funding round led by Salesforce Ventures, with participation from Echo Health Ventures and continued investment from Susa Ventures, Matrix Partners, and HC9 Ventures. This latest funding round, announced on May 14, 2026, brings Optura's total investment to over $25 million to date. The capital will be utilized to enhance its ROAI™ (Return on AI Investment) platform, which aims to provide measurable returns on AI investments in the healthcare sector.

Founded in 2025, Optura has quickly established itself as a key player in the healthcare AI space, generating over $120 million in value through its platform, which boasts a remarkable 700% ROAI™ for in-flight initiatives. The platform has been adopted by numerous multi-million-dollar healthcare organizations, with more than $2 billion in AI initiatives currently loaded into its system. Optura's technology is designed to help healthcare organizations assess the business value and viability of AI investments, prioritize these investments, and provide real-time visibility into their impact.

The funding comes at a critical juncture for the healthcare industry, which is currently experiencing a significant shift in its approach to AI. As organizations grapple with the challenge of translating AI investments into tangible outcomes, the demand for tools that can objectively measure ROI has never been greater. According to industry estimates, healthcare is expected to spend over $18 billion on AI this year, representing 46% of all healthcare investment. However, a staggering 95% of enterprise GenAI pilots have reportedly produced no measurable value, highlighting the urgent need for solutions like Optura's that can deliver accountability and results.

Optura's platform addresses a pressing issue within the healthcare sector: the gap between AI adoption and measurable results. As healthcare organizations face increasing pressure to move beyond experimentation and deliver concrete business outcomes, Optura provides a disciplined framework for evaluating AI investments. By systematically mapping an organization’s existing data into a unified knowledge layer, the platform enables healthcare leaders to make informed decisions grounded in their operational realities. This capability is crucial as organizations seek to navigate the complexities of AI integration while ensuring that their investments yield meaningful returns.

The implications of this funding round extend beyond Optura itself, signaling a broader trend in the healthcare sector towards accountability in AI investments. As enterprises increasingly prioritize measurable outcomes, the demand for platforms that facilitate this transition is likely to grow. Optura's recent success positions it well to capitalize on this trend, as healthcare organizations look for reliable partners to guide them through the evolving landscape of AI. The ongoing evolution of AI in healthcare underscores the importance of strategic investment in technologies that not only promise innovation but also deliver measurable results.